Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 05. Juni 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8937  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 178733  
   
Cross-population metabolome-wide Mendelian randomization study of prostate cancer risk.
Res Sq
Fuller H, Rohde R, Highland HM, Haessler J, Wu L, Graff M, Platz EA, Alkis T, Yu B, Boerwinkle E, Grove M, Kooperberg C, Peters U, North KE, Conti DV, Haiman CA, Young KL, Graff RE, Darst BF.
PMID: 42245788 [PubMed]


Detection of microplastics in bladder wash fluid obtained after cystoscopy in patients diagnosed with bladder cancer.
Front Public Health
Y, Ataman M, Tuna A.
PMID: 42245347 [PubMed - in process]


Validation, implementation, and impact of an AI model in routine practice for pathologic diagnosis of prostate cancer in an academic medical center.
J Pathol Inform
Udoh AI, Eyzaguirre E, Muthukumarana V, Thaker HM.
PMID: 42245328 [PubMed]


Therapeutic pressure drives the evolution of a protective ecotype characterized by AR-loss-induced senescence in prostate cancer.
Theranostics
He L, Jiang J, Liu S, Song H, Lu T, Hu Z, Li Y, Zhu H, Zhou Y, Li Z, Yang F, Zhang K, Zhang R, Wu T, Gan K, Zhao B, Zhang J, Si D, Zhang R, Shi C, Wen W, Han D, Xu C, Qin W.
PMID: 42244988 [PubMed - in process]


Comparative outcomes of focal HIFU versus active surveillance in low- and intermediate-risk localized prostate cancer: a 75-month retrospective cohort study.
Front Urol
Jaabou M, Buscarini M, Zaytoun O, Dovey Z, Hildebrand B, Awan M, Bada M, Al Ogaili M, Rabie A.
PMID: 42244908 [PubMed]


The Research Progress of Tumor-Associated Macrophages in Prostate Cancer.
J Immunol Res
Shen S, Tang Z, Guo C, Chen A, Mi Y.
PMID: 42244152 [PubMed - in process]


Integrative Transcriptomic Signature of tRNA-Derived Fragment Targets and Lactylation-Related Genes for Prostate Cancer Diagnosis.
Cancer Med
Wang L, Hu X, Wang B, Zhang Y, Yang J, Wang Y.
PMID: 42244032 [PubMed - in process]


Skin cancer mortality in Australian and New Zealand kidney transplant recipients: A population-based cohort study using linked health data, 1990-2019.
Br J Dermatol
Forcey DS, Rosales BM, Wyld ML, De La Mata N, Khosrotehrani K, Webster AC.
PMID: 42243641 [PubMed - as supplied by publisher]


Exposure-safety analyses of talazoparib in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trial.
J Pharmacokinet Pharmacodyn
Wang Y, Hadigol M, Lincha VR, Hoffman J, Azad AA, Agarwal N, Matsubara N, Zohren F, DeAnnuntis L, Wang DD.
PMID: 42243460 [PubMed - in process]


Development of ultrasonography for the detection of prostate cancer.
J Med Ultrason (2001)
Kuroda S, Yuzuriha S, Takahashi K, Naruse J, Nakajima N, Shoji S.
PMID: 42243380 [PubMed - as supplied by publisher]


Improved Shared Decision-making for Patients with Renal Cell Carcinoma: Results of the SDM-RCC Study.
Eur Urol Oncol
Bresser CC, Garvelink MM, van Dijk T, van der Linde N, van den Berg BMM, Dolk FCK, van Melick HHE, van der Nat PB, SDM-RCC Study Group.
PMID: 42242942 [PubMed - as supplied by publisher]


Doublet Versus Triplet Therapy in High-volume Metastatic Hormone-sensitive Prostate Cancer Patients with Bone Metastases: Results from the ARON-3 Study.
Eur Urol Oncol
Mandel PC, Wenzel M, Gandur Quiroga MN, Bourlon MT, Chun F, Myint ZW, Bernal L, Kopp RM, Juan Fita MJ, Büttner T, Fiala O, Li H, Bögemann M, Buchler T, Matthews D, Rizzo A, Ciccimarra F, Marques Monteiro FS, Soares A, Massari F, Steuber T, Santoni M.
PMID: 42242941 [PubMed - as supplied by publisher]


Reply to Selcuk Guven, Selim Soyturk, and Thomas Herrmann's Letter to the Editor re: Jeremy Y. Teoh, Francesco M. Bracco, Julius H. Wong, et al. A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial. Eur Urol Oncol 2026;86:111-15: My Vision for the Novel Transurethral Robotic Platform.
Eur Urol Oncol
Teoh JY.
PMID: 42242940 [PubMed - as supplied by publisher]


Sequential Imaging of Suspicion of Prostate Cancer: Reducing Overdiagnosis and Unnecessary Biopsy with Timely Diagnosis of Significant Cancer (SPROUT)-Prospective Multicentre Cohort Study Protocol.
Eur Urol Oncol
Sweere V, de Rooij M, Kil PJM, Israel B, van Basten JPA, Boellaard TN, Graus SA, van der Heijden AG, van der Hoeven EJRJ, Klaver OS, Mertens LS, Prette JF, Roelofs LAJ, Sedelaar JPM, Snoek AM, Somford DM, Barentsz JO, Van Melick HHE, van den Bergh RCN.
PMID: 42242939 [PubMed - as supplied by publisher]


Diagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer Undergoing (68)Ga-PSMA PET/CT.
J Nucl Med
Jia KY, Kuten J, Jia HY, Bent EH, Silveira P, Pasquini L, Nalavenkata S, Schoder H, Fox JJ, Yeh R, Razmaria AA.
PMID: 42242869 [PubMed - as supplied by publisher]


Transition Zone PSA Density Does Not Improve Detection of Clinically Significant Prostate Cancer Over Whole-Gland PSAD: A Volume-Stratified Analysis in 3,958 Patients.
Urol Int
Behnel N, Engelage L, Lumiani A, Buchner A, Stadelmeier LF, Sroka R, Tamalunas A.
PMID: 42241366 [PubMed - as supplied by publisher]


Diagnostic Value of PSMA-PET/CT for the Detection of Pelvic Lymph Node Metastasis in Intermediate and High-Risk Prostate Cancer.
Urol Int
Albarghouth MH, Leeder M, Leucht K, Seifert P, Freesmeyer M, Hakenberg OW, Grimm MO.
PMID: 42241365 [PubMed - as supplied by publisher]


Intravoxel incoherent motion diffusion-weighted imaging for early response stratification of neoadjuvant immune checkpoint inhibitor plus tyrosine kinase inhibitor in renal cell carcinoma: an exploratory study.
Jpn J Radiol
Kang H, Zhao J, Ding X, Li S, Xie L, Yu M, Wen X, Zhou S, Bai X, Wang Y, Liang Q, Peng C, Huang Q, Gu L, Wang H.
PMID: 42240729 [PubMed - as supplied by publisher]


Early vs. delayed primary local therapy and survival in de novo metastatic prostate cancer: target trial emulation.
World J Urol
Hassan AA, Aboelsaad AY, Gawad AMA, El-Dydamony EM, Algammal MI, Abdel-Al I, Koritenah AK, Abuelazayem TM, Salman MF, El-Wahsh AF, Ali MM, Shouman HA, Hindawy MA, Deif H, Wasfy IS.
PMID: 42240667 [PubMed - in process]


Image-guided percutaneous ablation techniques for the treatment of renal cell carcinoma: a primer for radiologists.
Abdom Radiol (NY)
Hernández-Mancera J, Remer EM, Graumann O, Borgbjerg J.
PMID: 42240648 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 178733    Seite 1 von 8937  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1